H. Link

1.8k total citations
41 papers, 862 citations indexed

About

H. Link is a scholar working on Immunology, Neurology and Hematology. According to data from OpenAlex, H. Link has authored 41 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Neurology and 9 papers in Hematology. Recurrent topics in H. Link's work include Myasthenia Gravis and Thymoma (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Peripheral Neuropathies and Disorders (6 papers). H. Link is often cited by papers focused on Myasthenia Gravis and Thymoma (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Peripheral Neuropathies and Disorders (6 papers). H. Link collaborates with scholars based in Germany, Sweden and Poland. H. Link's co-authors include S. Fredrikson, Manfred Gratzl, Reinhilde Jacobs, Govindan Dayanithi, R. Leo, Gertrud Stratmann, Tomas Olsson, Bao‐Guo Xiao, Natalia Teleshova and Pia Kivisäkk and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

H. Link

41 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Link Germany 17 373 179 149 146 139 41 862
John G. Gartner Canada 19 572 1.5× 41 0.2× 177 1.2× 293 2.0× 60 0.4× 52 1.5k
Katherine L. Neville United States 13 770 2.1× 90 0.5× 109 0.7× 31 0.2× 346 2.5× 15 1.3k
Miriam Davis United States 13 330 0.9× 77 0.4× 121 0.8× 42 0.3× 108 0.8× 18 892
Patricia A. Nelson United States 17 676 1.8× 186 1.0× 127 0.9× 53 0.4× 438 3.2× 27 1.4k
Taissa M. Kasahara Brazil 19 414 1.1× 104 0.6× 91 0.6× 32 0.2× 300 2.2× 33 846
Elizabeth Blankenhorn United States 5 315 0.8× 91 0.5× 82 0.6× 23 0.2× 112 0.8× 8 792
DJ Williamson United Kingdom 8 359 1.0× 34 0.2× 164 1.1× 257 1.8× 185 1.3× 8 1.0k
Yolanda S. Kap Netherlands 18 363 1.0× 61 0.3× 115 0.8× 15 0.1× 354 2.5× 33 872
S. J. Simmonds United Kingdom 11 725 1.9× 34 0.2× 104 0.7× 37 0.3× 46 0.3× 12 1.2k
Staley A. Brod United States 23 872 2.3× 222 1.2× 304 2.0× 31 0.2× 411 3.0× 70 1.6k

Countries citing papers authored by H. Link

Since Specialization
Citations

This map shows the geographic impact of H. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Link more than expected).

Fields of papers citing papers by H. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Link. The network helps show where H. Link may publish in the future.

Co-authorship network of co-authors of H. Link

This figure shows the co-authorship network connecting the top 25 collaborators of H. Link. A scholar is included among the top collaborators of H. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Link. H. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yi, et al.. (2003). Circulating CD4+CD25+ and CD4+CD25− T Cells in Myasthenia Gravis. Annals of the New York Academy of Sciences. 998(1). 318–319. 5 indexed citations
2.
Kivisäkk, Pia, Gunnar V. Alm, S. Fredrikson, & H. Link. (2000). Neutralizing and binding anti‐interferon‐β (IFN‐β) antibodies. A comparison between IFN‐β‐1a and IFN‐β‐1b treatment in multiple sclerosis. European Journal of Neurology. 7(1). 27–34. 56 indexed citations
3.
Wang, Huabing, Hulun Li, Fu‐Dong Shi, et al.. (2000). Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis. International Immunology. 12(10). 1381–1388. 29 indexed citations
4.
Huang, Yu-Min, Bao‐Guo Xiao, Volkan Özenci, et al.. (1999). Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. Journal of Neuroimmunology. 99(1). 82–90. 86 indexed citations
5.
Kivisäkk, Pia, Natalia Teleshova, Volkan Özenci, et al.. (1998). No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. Journal of Neuroimmunology. 91(1-2). 108–112. 14 indexed citations
6.
Hassan, H.T., W. Zeller, Johannes Clausen, et al.. (1997). Allogeneic Transplantation with CD34+-Selected Cells. Leukemia & lymphoma. 25(1-2). 145–151. 3 indexed citations
7.
Shi, Fu‐Dong, et al.. (1997). Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology. 73(1-2). 175–182. 37 indexed citations
8.
Nolte, M., Martin Werner, Reinhard von Wasielewski, et al.. (1996). Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 427(6). 561–565. 14 indexed citations
9.
Wang, Zeng‐Yu, H. Link, Bo Höjeberg, et al.. (1994). Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis. Cellular Immunology. 157(2). 353–368. 66 indexed citations
10.
Link, H., F. Herrmann, Walter E. Aulitzky, et al.. (1994). [Rational therapy with G-CSF and GM-CSF].. PubMed. 89(8). 429–41. 3 indexed citations
11.
12.
Qiao, Jie, et al.. (1993). T Cell Reactivity to Acetylcholine Receptor in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis. Cellular Immunology. 152(2). 394–404. 26 indexed citations
13.
Link, H., Govindan Dayanithi, & Manfred Gratzl. (1993). Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients.. Endocrinology. 132(2). 873–878. 23 indexed citations
14.
Mix, Eilhard, Jorge Correale, Tomas Olsson, Göran Solders, & H. Link. (1992). Calcium antagonists suppress experimental allergic neuritis (EAN). Journal of Autoimmunity. 5(1). 69–82. 6 indexed citations
15.
Correale, Jorge, Eilhard Mix, Tomas Olsson, et al.. (1991). CD5+ B cells and CD4−8− T cells in neuroimmunological diseases. Journal of Neuroimmunology. 32(2). 123–132. 26 indexed citations
16.
Martino, Gianvito, Tomas Olsson, S. Fredrikson, et al.. (1991). Cells producing antibodies specific for myelin basic protein region 70–89 are predominant in cerebrospinal fluid from patients with multiple sclerosis. European Journal of Immunology. 21(12). 2971–2976. 30 indexed citations
17.
Freund, M., Peter von Wussow, H. Mohr, et al.. (1988). Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b. Annals of Hematology. 57(5). 311–315. 11 indexed citations
18.
Lindblom, Bertil, et al.. (1988). Distribution of group-specific component subtypes in multiple sclerosis. Acta Neurologica Scandinavica. 78(5). 443–444. 10 indexed citations
19.
Wilke, H., Hans‐Joachim Schmoll, P. Preusser, et al.. (1988). Folinic Acid (CF)/5-Fluorouracil (FUra) Combinations in Advanced Gastrointestinal Carcinomas. Advances in experimental medicine and biology. 244. 233–243. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John G. Gartner Breakdown of academic impact, for papers by Katherine L. Neville Breakdown of academic impact, for papers by Miriam Davis Breakdown of academic impact, for papers by Patricia A. Nelson Breakdown of academic impact, for papers by Taissa M. Kasahara Breakdown of academic impact, for papers by Elizabeth Blankenhorn Breakdown of academic impact, for papers by DJ Williamson Breakdown of academic impact, for papers by Yolanda S. Kap Breakdown of academic impact, for papers by S. J. Simmonds Breakdown of academic impact, for papers by Staley A. Brod
Rankless by CCL
2026